Related Experiment Video
Updated: Jun 16, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
[Report of the tenth meeting of the WHO Technical Advisory Group on Leprosy Control]
Norihisa Ishii1, Sumana Barua, Shuichi Mori
1Leprosy Research Center, National Institute of Infectious Diseases, Tokyo, Japan. norishii@nih.go.jp
Abstract:
The tenth meeting of the WHO Technical Advisory Group (TAG) on Leprosy Control was held in New Delhi, India on 23rd April 2009. The meeting was chaired by Professor WCS Smith and attended by TAG members, several experts, WHO secretariat, and members of the technical bodies of International Leprosy Association (ILA) and the International Federation of Anti-Leprosy Associations (ILEP) also attended the meeting.
Related Concept Videos
Leishmaniasis
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Antiprotozoal Agents
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
